Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna). 2017;124(8):901–5.
Article
Google Scholar
Khedr EM, Fawi G, Abbas MA, Mohammed TA, El-Fetoh NA, Attar GA, Zaki AF. Prevalence of parkinsonism and Parkinson’s disease in Qena governorate/Egypt: a cross-sectional community-based survey. Neurol Res. 2015;37(7):607–18.
Article
Google Scholar
Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EM. Systematic review of the relationship between vitamin D and Parkinson’s disease. J Park Dis. 2016;6(1):29–37.
CAS
Google Scholar
Peterson AL, Murchison C, Zabetian C, Leverenz JB, Watson GS, Montine T, Carney N, Bowman GL, Edwards K, Quinn JF. Memory, mood, and vitamin D in persons with Parkinson’s disease. J Park Dis. 2013;3(4):547–55.
Article
CAS
Google Scholar
Topal K, Paker N, Bugdayci D, Ozer F, Tekdos D. Bone mineral density and vitamin D status with idiopathic Parkinson’s disease. Osteoporos Int. 2010;21:S141–2.
Google Scholar
Van den Bos F, Speelman A, van Nimwegen M, van der Schouw Y, Backx F, Bloem B, et al. Bone mineral density and vitamin D status in Parkinson’s disease patients. J Neurol. 2013;260:754–60.
Article
CAS
Google Scholar
Evatt M, Delong M, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348–52.
Article
Google Scholar
Sleeman I, Aspray T, Lawson R, Coleman S, Duncan G, Khoo TK, Schoenmakers I, Rochester L, Burn D, Yarnall A. The Role of Vitamin D in Disease Progression in Early Parkinson's Disease. J Parkinsons Dis. 2017;7(4):669–75.
Article
CAS
Google Scholar
Sonnenberg J, Luine V, Krey L, Christakos S. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology. 1986;118:1433–9.
Article
CAS
Google Scholar
Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res. 2006;83:1179–89.
Article
CAS
Google Scholar
Kang H, Schuman EM. Intracellular Ca (2+) signaling is required for neurotrophin-induced potentiation in the adult rat hippocampus. Neurosci Lett. 2000;282:141–4.
Article
CAS
Google Scholar
Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36:193–6.
Article
CAS
Google Scholar
Smith MP, Fletcher-Turner A, Yurek DM, Cass WA. Calcitriol protection against dopamine loss induced by intracerebroventricularadministration of 6-hydroxydopamine. Neurochem Res. 2006;31:533–9.
Article
CAS
Google Scholar
Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci. 2006;1074:261–71.
Article
CAS
Google Scholar
Eyles D, Smith S, Kinobe R, Hewison M, McGrath J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21–30.
Article
CAS
Google Scholar
Evatt M, DeLong M, Kumari M, Auinger P, McDermott M, Tangpricha V. High prevalence of Hypovitaminosis D status in patients with early Parkinson disease. Neurology. 2011;68:314–9.
Google Scholar
Kim JS, Kim YI, Song C, Yoon I, Park JW, Choi YB, Kim HT, Lee KS. Association of vitamin D receptor gene polymorphism and Parkinson’s disease in Koreans. J Korean Med Sci. 2005;20(3):495–8.
Article
CAS
Google Scholar
Wang T, Tavera-Mendoza L, Laperriere D, Libby E, MacLeod N, Nagai Y, et al. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005;19:2685–95.
Article
CAS
Google Scholar
Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol. 2007;103:538.
Article
CAS
Google Scholar
Newmark H, Newmark J. Vitamin D and Parkinson's disease--a hypothesis. Mov Disord. 2007;22(4):461–8.
Article
Google Scholar
Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Abnormal bone and calcium metabolism in immobilized Parkinson’s disease patients. Mov Disord. 2005;20:1598–603.
Article
Google Scholar
Hughes A, Ben-Shlomo Y, Daniel S, Lees A. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology. 1992;42(6):1142–6.
Article
CAS
Google Scholar
Goetz C, Poewe W, Rascol O, Sampaio C, Stebbins G, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. The Movement Disorder society Task Force on rating scales for Parkinson’s disease. Mov Disord. 2004;19(9):1020–8.
Article
Google Scholar
Fahn S, Elton R, members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson’s disease; 1987. p. 153–63.
Google Scholar
Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A. Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord. 2008;23(7):998–1005.
Article
Google Scholar
Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67(7):808–11.
Article
Google Scholar
Bischoff-Ferrari H, Giovannucci E, Willett W, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18–28.
Article
CAS
Google Scholar
Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004–13.
Article
CAS
Google Scholar
Buell J, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing “D”ecline? Mol Asp Med. 2008;29(6):415–22.
Article
CAS
Google Scholar
Fullard M, Xie S, Marek K, Stern M, Jennings D, Siderowf A, et al. Vitamin D in the Parkinson associated risk syndrome (PARS) study. Mov Disord. 2017;2(11):1636–40.
Article
Google Scholar
Sleeman I, Che Z, Counsell C. Risk of fracture amongst patients with Parkinson’s disease and other forms of parkinsonism. Parkinsonism Relat Disord. 2016;29:60–5.
Article
Google Scholar
Peterson A, Mancini M, Horak F. The relationship between balance control and vitamin D in Parkinson’s disease-a pilot study. Mov Disord. 2013;28:1133–7.
Article
Google Scholar
Chitsaz A, Maracy M, Basiri K, Boroujeni MI, Tanhaei AP, et al. 25-Hydroxyvitamin D and severity of Parkinson’s disease. Int J Endocrinol. 2013;689149:4.
Google Scholar
Pfeifer M, Begerow B, Minne H. Vitamin D and muscle function. Osteoporos Int. 2002;13:187–94.
Article
CAS
Google Scholar
Chen H, Zhang S, Hernan M, Willett W, Ascherio A. Dietary intakes of fat and risk of Parkinson’s disease. Am J Epidemiol. 2003;157(11):1007–14.
Article
Google Scholar
Sanchez B, Relova J, Gallego R, Ben-Batalla I, Perez-Fernandez R. 1,25 Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantianigra and striatum. J Neurosci Res. 2009;87:723–32.
Article
CAS
Google Scholar
Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, et al. 1alpha, 25- dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2009;17:703–17.
Article
CAS
Google Scholar
Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48(7):1247–57.
Article
CAS
Google Scholar
Forman J, Bischoff-Ferrari H, Willett W, Stampfer M, Curhan G. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005;46(4):676–82.
Article
CAS
Google Scholar
Poole K, Loveridge N, Barker P. Reduced vitamin D in acute stroke. Stroke. 2006;37(1):243–5.
Article
CAS
Google Scholar
Hendrie HC, Albert MS, Butters MA. The NIH cognitive and emotional health project: report of the critical evaluation study committee. Alzheimers Dement. 2006;2:1):12–32.
Article
Google Scholar